Laboratorio Reig Jofre, S.A. (FRA:FEQ1)

Market Cap	211.62M +1.7%
Revenue (ttm)	330.34M -1.0%
Net Income	4.25M -55.5%
EPS	0.05
Shares Out	n/a
PE Ratio	49.79
Forward PE	96.19
Dividend	0.04 (1.51%)
Ex-Dividend Date	May 15, 2025

Volume	n/a
Average Volume	n/a
Open	2.540
Previous Close	2.590
Day's Range	2.540 - 2.560
52-Week Range	2.450 - 3.250
Beta	n/a
RSI	36.46
Earnings Date	Feb 27, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmacy, food, and animal food. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements und...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,437
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FEQ1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 341.37 million, an increase of 7.36% compared to the previous year's 317.95 million. Earnings were 10.38 million, an increase of 10.36%.